Tolterodine Tartrate

Tolterodine Tartrate
(toll tear’ oh deen)
Detrol, Detrol LADNC
PREGNANCY CATEGORY C
Drug class
Antimuscarinic
Therapeutic Actions
Competitively blocks muscarinic receptor sites; bladder contraction is mediated by muscarinic receptors—blocking these receptors decreases bladder contraction.
Indications
  • Treatment of overactive bladder in patients with symptoms of urinary frequency, urgency or incontinence
Available Forms
Tablets—1, 2 mg; ER capsulesDNC—2, 4 mg
Dosages
Adults
2 mg PO bid, may be lowered to 1 mg PO bid based on individual response; ER capsules—4 mg PO taken once daily; may be lowered to 2 mg once daily based on response.
Pediatric patients
Safety and efficacy not established.
Patients with hepatic and renal impairment
Reduce dosage to 1 mg PO bid (2 mg daily ER capsules) and monitor patient.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 21, 2016 | Posted by in NURSING | Comments Off on Tolterodine Tartrate

Full access? Get Clinical Tree

Get Clinical Tree app for offline access